TrialClinical and molecular hepatology2017

Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B.

Kwan Sik Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.